APP announces business separation
APP announces business separation
SCHAUMBURG -- APP Pharmaceuticals Inc. announced it completed the tax-free separation of its proprietary business. APP Pharmaceuticals is a manufacturer of multi-source and branded injectable pharmaceutical products for acute medical care, both in patient and ambulatory settings. Through its broad portfolio of therapeutic products, APP helps provide ongoing affordable health care for millions of people in the United States and Canada fighting critical illnesses.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.